Haris Ali, M.D.

2001, M.D., Rawalpindi Medical College, Rawalpindi, Pakistan
2009-2012, University of Texas Southwest (Hematology/Medical Oncology)
2012-2013, Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
2004-2007, Loma Linda University Medical Center, Loma Linda, CA
2003-2004, Intern, Internal Medicine, Harbor Hospital Center, University of Maryland, Baltimore, MD
2020-present, Associate Professor, Division of Leukemia, Department of Hematology and Hematopoietic Cell Transplantation (HCT), City of Hope, Duarte, CA
2013-2020, Assistant Clinical Professor, Division of Leukemia, Department of Hematology and Hematopoietic Cell Transplantation (HCT), City of Hope, Duarte, CA
2013-present, Staff Physician, Division of Leukemia, Department of Hematology and Hematopoietic Cell Transplantation (HCT), City of Hope, Duarte, CA
2011 & 2012, Recognition Award for First Place in American Society of Clinical Oncology In-service Exam
2011 & 2012, Recognition Award For First Place in American Society of Hematology In-service Exam
2006, Best Poster, American College of Physicians, California Chapter poster competition
2003, Winner Doctor’s Dilemma, American College of Physicians, Maryland Chapter
2001, Highest ranking medical school graduate, class rank 3rd of 250
1999, Distinction in pathology
American Society of Blood and Marrow Transplantation
American Society of Clinical Oncology
American Society of Hematology
Associate of American College Physician
- K.S. Sandhu, S. Dadwal, D. Yang, M. Mei, J. Palmer, A. Salhotra, M.A. Malki, A. Aribi, H. Ali, S. Khaled, S.J. Forman, D. Snyder, R. Nakamura, A.S. Stein, G. Marcucci, I. Aldoss, V. Pullarkat, Outcome of Allogeneic Hematopoietic Cell Transplantation after Venetoclax and Hypomethylating Agent Therapy for Acute Myelogenous Leukemia, Biology of Blood and Marrow Transplantation. 26 (2020) e322–e327.
- I. Aldoss, J. Zhang, M. Mei, M.M.A. Malki, S. Arslan, D. Ngo, A. Aribi, H. Ali, K. Sandhu, A. Salhotra, P. Koller, S. Khaled, A. Artz, D. Snyder, R. Nakamura, S.J. Forman, A.S. Stein, G. Marcucci, V. Pullarkat, Venetoclax and hypomethylating agents in FLT3-mutated acute myeloid leukemia, American Journal of Hematology. 95 (2020) 1193–1199.
- A. Salhotra, D. Yang, S. Mokhtari, M.M.A. Malki, H. Ali, K.S. Sandhu, A. Aribi, S. Khaled, M. Mei, E. Budde, D. Snyder, T. Cao, R. Spielberger, G. Marcucci, V. Pullarkat, S.J. Forman, R. Nakamura, A. Stein, I. Aldoss, Outcomes of Allogeneic Hematopoietic Cell Transplantation after Salvage Therapy with Blinatumomab in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia, Biology of Blood and Marrow Transplantation. 26 (2020) 1084–1090.
- K. Gowin, K. Ballen, K.W. Ahn, Z.H. Hu, H. Ali, M.O. Arcasoy, R. Devlin, M. Coakley, A.T. Gerds, M. Green, V. Gupta, G. Hobbs, T. Jain, M. Kandarpa, R. Komrokji, A.T. Kuykendall, K. Luber, L. Masarova, L.C. Michaelis, S. Patches, A.C. Pariser, R. Rampal, B. Stein, M. Talpaz, S. Verstovsek, M. Wadleigh, V. Agrawal, M. Aljurf, M.A. Diaz, B.R. Avalos, U. Bacher, A. Bashey, A.M. Beitinjaneh, J. Cerny, S. Chhabra, E. Copelan, C.S. Cutler, Z. DeFilipp, S.M. Gadalla, S. Ganguly, M.R. Grunwald, S.K. Hashmi, M.A. Kharfan-Dabaja, T. Kindwall-Keller, N. Krger, H.M. Lazarus, J.L. Liesveld, M.R. Litzow, D.I. Marks, S. Nathan, T. Nishihori, R.F. Olsson, A. Pawarode, J.M. Rowe, B.N. Savani, M.L. Savoie, S. Seo, M. Solh, R. Tamari, L.F. Verdonck, J.A. Yared, E. Alyea, U. Popat, R. Sobecks, B.L. Scott, R. Nakamura, R. Mesa, W. Saber, Survival following allogeneic transplant in patients with myelofibrosis, Blood Advances. 4 (2020) 1966–1973.
- M. Jagasia, M.A. Perales, M.A. Schroeder, H. Ali, N.N. Shah, Y.B. Chen, S. Fazal, F.W. Dawkins, M.C. Arbushites, C. Tian, L. Connelly-Smith, M.D. Howell, H.J. Khoury, Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1) : a multicenter, open-label phase 2 trial, Blood. 135 (2020) 1739–1749.
- H. Ali, A. Salhotra, B. Modi, R. Nakamura, Ruxolitinib for the treatment of graft-versus-host disease, Expert Review of Clinical Immunology. 16 (2020) 347–359.
- M.A. Schroeder, H.J. Khoury, M. Jagasia, H. Ali, G.J. Schiller, K. Staser, J. Choi, L. Gehrs, M.C. Arbushites, Y. Yan, P. Langmuir, N. Srinivas, M. Pratta, M.-A. Perales, Y.-B. Chen, G. Meyers, J.F. DiPersio, A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease, Blood Advances. 4 (2020) 1657–1669.
- A. Salhotra, S. Hui, D. Yang, S. Mokhtari, M. Mei, M.M.A. Malki, I. Aldoss, H. Ali, K.S. Sandhu, A. Aribi, S. Khaled, S. Dandapani, K. Peng, J.B. Teh, J. Murata-Collins, E. Budde, S. Dadwal, V. Pullarkat, D. Snyder, R. Spielberger, J. Wong, S. Armenian, G. Marcucci, S.J. Forman, R. Nakamura, A. Stein, Long-Term Outcomes of Patients with Acute Myelogenous Leukemia Treated with Myeloablative Fractionated Total Body Irradiation TBI-Based Conditioning with a Tacrolimus- and Sirolimus-Based Graft-versus-Host Disease Prophylaxis Regimen : 6-Year Follow-Up from a Single Center, Biology of Blood and Marrow Transplantation. 26 (2020) 292–299.
- M. Mei, N.-C. Tsai, S. Mokhtari, M.M.A. Malki, H. Ali, A. Salhotra, K. Sandhu, S. Khaled, E. Smith, D. Snyder, G. Marcucci, S.J. Forman, V. Pullarkat, A. Stein, I. Aldoss, R. Nakamura, Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplant with Fludarabine and Melphalan Conditioning and Tacrolimus/Sirolimus as Graft-versus-Host Disease Prophylaxis in Patients with Acute Lymphoblastic Leukemia, Biology of Blood and Marrow Transplantation. (2020).
- I. Aldoss, S. Dadwal, J. Zhang, B. Tegtmeier, M. Mei, S. Arslan, M.M.A. Malki, A. Salhotra, H. Ali, A. Aribi, K. Sandhu, S. Khaled, D. Snyder, R. Nakamura, A.S. Stein, S.J. Forman, G. Marcucci, V. Pullarkat, Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agents, Blood Advances. 3 (2019) 4043–4049.
- R. Gupta, F. Jamal, D. Yang, C. Chendri, I. Aldoss, M.A. Malki, M. Mei, A. Salhotra, S. Dobrin, M. Tran, K. Venkataraman, J. Palmer, A.S. Stein, K. Sandhu, S. Khaled, A. Aribi, G. Marcucci, S.J. Forman, D. Snyder, R. Nakamura, H. Ali, V. Pullarkat, Pulmonary hypertension is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation for myelofibrosis, Bone Marrow Transplantation. 55 (2019) 877–883.
- A. Salhotra, M. Afkhami, D. Yang, S. Mokhtari, M. Telatar, D. Gu, R.K. Pillai, D.D. Weisenburger, J. Mu